INFORS HT Opens New Offices in the USA
News Jan 06, 2014
On January 1st 2014, INFORS HT has opened new offices in the USA.
INFORS HT has, until now, been represented in the USA by ATR (Appropriate Technical Resources Inc.). From January 1st 2014, INFORS HT is going to take over this part of the ATR business - including its infrastructure, the existing customer relations, and full complement of staff.
In order to guarantee a seamless continuity of service to their customers, all sales and service offices as well as production teams will remain unchanged, as will any current contact personnel.
By increasing its presence in the USA, INFORS HT will not only expand its customer base but give its customers direct day-to-day contact with INFORS HT representatives and no longer via a third party.
Marcel Brauchli, CEO of INFORS HT, points out: “We’re proud of our new branches and look forward to having direct contact with our customers in the USA. We’re convinced that, in this way, we can improve customer relations and build more successful long term partnerships.”
This new direct contact will also bring about an added value to customers. They will have access to a committed team who have a wealth of experience, technical know-how and innovative thinking that is second-to-none.
The new CEO of Infors USA Inc., Simon Egli, holds a master degree in biotechnology engineering from the University of Waedenswil (CH).
Before joining INFORS HT at the headquarters in Switzerland, he worked in various bioprocess production and validation positions at a management level. He has been with INFORS HT for 3 years.
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018
2nd International Conference on Food Science and Bioprocess Technology
Oct 01 - Oct 03, 2018